Clinical Trial Update: RCT of Cognitive Therapy, Paroxetine, Combined CT and Paroxetine and Placebo [Phase 4]

View source ↗

Summary

Phase 4 randomized trial update evaluating cognitive therapy, paroxetine, their combination, and placebo for phobic disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phobic Disorders

Drugs mentioned

• Paroxetine (Paroxetine hydrochloride)
• cognitive therapy

Snippet

Sponsor: Norwegian University of Science and Technology | Conditions: Phobic Disorders | Phase 4 | Status: COMPLETED